NCT03515291View on ClinicalTrials.gov

A Trial of Cardiac Injections of iMP Cells During CABG Surgery

PHASE2UnknownINTERVENTIONAL

Enrollment

50

Participants

Timeline

Start Date

January 31, 2020

Primary Completion Date

January 31, 2021

Study Completion Date

July 31, 2021

Conditions

Myocardial Fibrosis

Interventions

BIOLOGICAL

iMP cells

Immunomodulatory progenitor cells

OTHER

Control injection

Cell suspension solution

Sponsors

Lead Sponsor

Cell Therapy Ltd.

All Listed Sponsors

collaborator

Royal Brompton & Harefield NHS Foundation Trust

OTHER

lead

Cell Therapy Ltd.

INDUSTRY